European Pharmaceutical Review

AUGUST 23, 2022

Of the cGMP letters, three major types of violations – deficiencies in process validation, documentation practices (data integrity) and quality control – accounted for 26 percent, 21 percent and 15 percent of warning letters respectively. Overall, validation, documentation and quality control were the major cGMP violations.

FDA 90

FDA Documentation Packaging Labelling 90

The FDA Law Blog

OCTOBER 5, 2022

In 2015, FDA issued a Warning Letter to Kind LLC because, among other things, the company labeled products as healthy whereas these products provided more saturated fat per serving than permitted by the regulatory definition. The term healthy, as an implied nutrient claim, was first defined by FDA in 1994.

FDA 52

FDA Labelling Packaging Documentation 52

The FDA Law Blog

FEBRUARY 21, 2024

This amendment marks the first significant revision of Part 820 since 1996, which established the Quality System (QS) regulation and “included requirements related to the methods used in, and the facilities and controls used for, designing, manufacturing, packaging, labeling, storing, installing, and servicing of devices intended for human use.”

FDA 59

FDA Labelling Packaging Documentation 59

The Checkup by Singlecare

FEBRUARY 16, 2024

10 potential health benefits of NAC Some of NAC’s uses are time-tested and well-documented, like its efficacy in treating acetaminophen overdose. One small study from 2015 showed that some people who took NAC for four weeks saw decreases in systolic blood pressure and diastolic blood pressure. But it’s not just a long-term treatment.

Immunization 83

Immunization Dosage Packaging FDA 83

ISPE

JULY 19, 2023

™ started in 2015 at the ISPE Germany/Austria/Switzerland (D/A/CH) “Plug and Produce” workshop in Basel, Switzerland. Then in 2015, ISPE in Europe founded the Special Interest Group (SIG) Pharma 4.0™, Is the vendors’ documentation complete in order to assess GxP risks and GxP compliance?

Documentation 98

Documentation FDA Labelling Communication 98

pharmaphorum

OCTOBER 30, 2022

The two groups were also separated by a sizeable time difference, with data from the control group ranging between 1990 and 2015, while Study 03-133 started enrolling patients in 2004. Changes in standard and supportive care over the time period could also have skewed the results, said the FDA reviewer.

FDA 52

FDA Documentation Labelling Immunization 52

Druggist

FEBRUARY 17, 2021

Most pharmacies sell hydrocortisone cream as ‘own’ label product or branded products, foe example HC45 Hydrocortisone cream. The mechanism action of local anaesthetic creams is well defined, and their effectiveness well documented. 2015 Jul;135(7):1790-1800. Epub 2015 Feb 23. Who can use Lanacane cream?

Compounding 98

Compounding Documentation Labelling 98